| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |